Aspire Biopharma to Acquire Automotive Driver Control Business for $30.8 Million

On June 10, 2026, Aspire Biopharma Holdings, Inc. entered into a definitive Purchase Agreement with FireFish TopCo, LLC to acquire its automotive driver control systems business for approximately $30.8 million. The deal includes $30 million in cash plus an $800,000 credit for deferred revenue, adjusted for income tax obligations and indebtedness. The acquired business focuses on electronic driver control systems, vehicle electrification, and safety components. A key condition of the closing is the delivery of a PCAOB audit for fiscal years 2024 and 2025, reflecting an unqualified opinion and a minimum gross profit (minus capital expenditures) of $12 million. Aspire Biopharma maintains the right to terminate the agreement if this audit is not obtained by September 10, 2026. The agreement includes a $3.5 million termination fee payable under specific circumstances. This acquisition represents a significant expansion for Aspire into the automotive technology sector. The closing is subject to customary conditions and regulatory approvals.